Cooley et al. investigated the effect on donor KIR B-haplotype status on transplantation outcome in unrelated matched HSCT in AML patients with respect to the centromeric and telomeric A- and B-haplotype motifs on the KIR locus[30]. This evidence concerns the gene KIR3DL1 and acute myeloid leukemia.